Future improvements in acute myeloid leukemia (AML) therapy will require treatments that more effectively eradicate leukemia, while at the same time reduce the severity of chemotherapeutic side effects such as bleeding due to thrombocytopenia. The proposed project will focus on both of these issues. One approach to improving AML chemotherapy is to identify key differences in proteins that impact the function of important transporters in AML. We propose that the vulnerability of AML to both conventional and newer targeted chemotherapy can be exploited by identifying key proteins that affect the function of the ABC transporter, ABCC4, a protein highly expressed in AML. Our preliminary data reveal that MPP1, a PDZ-binding protein that is highly expressed in AML physically interacts with ABCC4 through its PDZ-motif. Importantly, high expression of MPP1 is a poor prognostic factor in AML. A central hypothesis driving our proposal is that the protein interaction between ABCC4 and MPP1, mediated by ABCC4-PDZ motif, is crucial to the MPP1 driven hematopoietic progenitor transformation as well as ABCC4 mediated export of chemotherapeutic drugs. Our second hypothesis relates to a novel mechanism impacting platelet production. This hypothesis was based upon recent GWAS studies that identified ABCC4 as one of the novel genetic determinants of platelet formation during megakaryopoiesis (platelet formation) (2, 7). It is unknown if ABCC4 has a role in megakaryopoiesis. We propose highly integrated studies that focus on the ABCC4 transporter, a protein that is expressed megakaryocytes, the cell responsible for the genesis of platelets. (1) Using both in vitro and in vivo AML models and cell lines, we will investigate how ABCC4 and MPP1 interact to produce transformation/immortalization of hematopoietic progenitors as well as confer resistance to chemotherapeutic drugs in AML, (2) Determine the domains of MPP1 required to alter ABCC4 function, and (3) Elucidate how ABCC4 regulates the formation of platelets from megakaryocytes.

Public Health Relevance

We have identified important roles for the ABC transporter, ABCC4 in acute myeloid leukemia (AML) as well as in formation of platelets. Our preliminary studies suggest ABCC4 interaction with a protein contributes to AML. Additionally, ABCC4 has a crucial role for ABCC4 in normal platelet formation. This knowledge will enhance treatment of AML as well as diseases impacted by alterations in platelet number and function.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA194206-01A1
Application #
9176819
Study Section
Xenobiotic and Nutrient Disposition and Action Study Section (XNDA)
Program Officer
Mufson, R Allan
Project Start
2016-07-01
Project End
2021-06-30
Budget Start
2016-07-01
Budget End
2017-06-30
Support Year
1
Fiscal Year
2016
Total Cost
$503,435
Indirect Cost
$222,970
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
Pitre, Aaron; Ge, Yubin; Lin, Wenwei et al. (2017) An unexpected protein interaction promotes drug resistance in leukemia. Nat Commun 8:1547
Murray, Jayne; Valli, Emanuele; Yu, Denise M T et al. (2017) Suppression of the ATP-binding cassette transporter ABCC4 impairs neuroblastoma tumour growth and sensitises to irinotecan in vivo. Eur J Cancer 83:132-141
Liu, Chengcheng; Janke, Laura J; Yang, Jun J et al. (2017) Differential effects of thiopurine methyltransferase (TPMT) and multidrug resistance-associated protein gene 4 (MRP4) on mercaptopurine toxicity. Cancer Chemother Pharmacol 80:287-293
Wijaya, Juwina; Fukuda, Yu; Schuetz, John D (2017) Obstacles to Brain Tumor Therapy: Key ABC Transporters. Int J Mol Sci 18:
Drenberg, C D; Hu, S; Li, L et al. (2016) ABCC4 Is a Determinant of Cytarabine-Induced Cytotoxicity and Myelosuppression. Clin Transl Sci 9:51-9
Morfouace, Marie; Cheepala, Satish; Jackson, Sadhana et al. (2015) ABCG2 Transporter Expression Impacts Group 3 Medulloblastoma Response to Chemotherapy. Cancer Res 75:3879-89
Cheepala, Satish; Hulot, Jean-Sebastien; Morgan, Jessica A et al. (2013) Cyclic nucleotide compartmentalization: contributions of phosphodiesterases and ATP-binding cassette transporters. Annu Rev Pharmacol Toxicol 53:231-53
Furmanski, Brian D; Hu, Shuiying; Fujita, Ken-Ichi et al. (2013) Contribution of ABCC4-mediated gastric transport to the absorption and efficacy of dasatinib. Clin Cancer Res 19:4359-4370
Fukuda, Yu; Schuetz, John D (2012) ABC transporters and their role in nucleoside and nucleotide drug resistance. Biochem Pharmacol 83:1073-83
Zhang, Yuanyuan; Li, Fei; Patterson, Andrew D et al. (2012) Abcb11 deficiency induces cholestasis coupled to impaired ?-fatty acid oxidation in mice. J Biol Chem 287:24784-94

Showing the most recent 10 out of 12 publications